Cambridge, UK, 16th October 2018: The end of October sees the return of the Immunology of Diabetes Society for their 16th congress, and an opportunity to see presentations from two of PredictImmune’s founders.
IDS October 25-2, 2018 | Venue: QEII Centre, London, UK
The 16th IDS will include talks on a wide range of current topics of interest to the diabetes community, including ground-breaking technologies, cell-based and advanced therapeutics, immunopathology of type 1 diabetes, pathways to beta cell failure, updates from the Networks – nPod, TEDDY, Trialnet and the Immune Tolerance Network, as well as an adversarial debate and a “balloon debate”.
The conference will include presentations from leading speakers in the field, including:
Friday 26th October, 11:00-12:30 Session 4 (Update from Our Networks): TEDDY
Dr Eoin McKinney, will present an update on TEDDY transcriptomics: patterns of progression in T1D at 11:45
Saturday 27th October, 08:30-09:15 Keynote Presentation
Prof. Ken Smith, will present “Diagnosis versus prognosis in immune-mediated disease: insights from T and B cell genomics” at 08:30
Find out more here: www.ids2018.org
The scientific programme includes all aspects of our specialty, ranging from basic science to clinical practice guidelines. A world class faculty will gather for UEG week to present the latest research and state-of-the art clinical practice.